ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991

Murphy Withdraws From SU Position

October 17, 1986

M.D. Anderson Closes Trials following FDA Requests for Data

February 16, 1996

Greenwald: Report’s Implementation Will Require Budget Raise

June 27, 1997

Three Community Based Programs Slated for Early Phaseout, Others Modified, Provided NCAB Agrees

February 29, 1980

Preliminary Study Results Show DES In Utero Exposure May Not Be Threat Originally Feared

February 17, 1978